EU seeks more data from GLP-1 drugmakers on suicidal thoughts

7 months ago
968

The EU's drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs, including Novo Nordisk's popular therapies Ozempic and Wegovy, to further investigate suicidal thoughts in some patients taking them. Fiona Jones reports.

Loading comments...